LUCID DIAGNOSTICS INC. news, videos and press releases
For more news please use our advanced search feature.
LUCID DIAGNOSTICS INC. - More news...
LUCID DIAGNOSTICS INC. - More news...
- Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results
- Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans
- Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022
- Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination
- Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference
- Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
- PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study
- PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
- Lucid Diagnostics to Hold a Business Update Conference Call on March 28, 2022
- Lucid Diagnostics to Participate in the LSI USA ’22 Emerging Medtech Summit
- PAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing Growth
- Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference
- Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference
- PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth
- Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
- PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
- Lucid Diagnostics’ EsoGuard Esophageal DNA Test Wins “Diagnostics Innovation of the Year” Award
- Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
- Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
- Lucid Diagnostics Announces Pricing of Initial Public Offering